Skip to main content
. 2020 Jan 23;39(2):240-248. doi: 10.2478/jomb-2019-0035

Table 3. Metabolic characteristics.

*for the level of significance of 0.05 §Student t test ₤Chi-square test ¥Mann Whitney test BMI=body mass index, LAP=lipid accumulation products, LDL=low density lipoprotein, HDL=high density lipoprotein, CRP=C reactive protein

Glucose metabolism disorders: PA vs. NFA+HT p=0.431; PA vs. CS+SCS p=0.175; NFA+HT vs. CS+SCS p=0.043.

Characteristic mean (SD) or med (Q1 – Q3) Total Groups p*
PA NFA+HT CS+SCS
Weight (kg) 80.61 (17.63) 79.88 (15.86) 83.57 (20.57) 75.53 (12.26) 0.255§
Height (cm) 167.02 (13.86) 169.65 (9.81) 165.81 (18.41) 165.4 (25.64) 0.446§
BMI (kg/m2) 28.07 (4.48) 27.72 (4.57) 28.53 (4.04) 27.68 (5.30) 0.690§
Waist (cm) 92.88 (13.47) 90.73 (10.61) 94.72 (13.95) 92.37 (16.38) 0.468§
Glycaemia (mmol/L) 5.33 (1.11) 5.32 (1.18) 5.25 (1.02) 5.48 (1.17) 0.745§
Glucose metabolism disorders, n (%)
Diabetes mellitus 11 (39.3) 2 (18.2) 4 (50.0) 5 (55.6) 0.179₤
Glucose intolerance 17 (60.7) 9 (81.8) 4 (50.0) 4 (44.4)
Cholesterol (mmol/L) 5.94 (1.22) 5.65 (1.11) 6.04 (1.12) 6.20 (1.51) 0.460§
LDL-cholesterol (mmol/L) 3.78 (1.03) 3.62 (0.91) 3.91 (0.97) 3.83 (1.32) 0.547§
HDL-cholesterol (mmol/L) 1.37 (0.39) 1.34 (0.38) 1.32 (0.39) 1.51 (0.39) 0.166§
TG (mmol/L) 1.80 (1.2–2.2) 1.60 (1–2.2) 1.70 (1.22–2.07) 2 (1.05–2.45) 0.310¥
LAP 48.10 (28–82.8) 41.6 (23.4–75.25) 52.75 (34.5–83.9) 55.1 (27.2–90.2) 0.638¥
CRP (mg/L) 2.10 (1.37–4.55) 2 (1.35–4.9) 2.1 (1.02–4.0) 2.78 (1.5–3.4) 0.777¥